INTEGER HOLDINGS CORPORATION Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
INTEGER HOLDINGS CORPORATION (ITGR) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of -$1.18 million for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2026-08-04
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-07-03 was -$1.18M.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-12-31 was -$1.61M.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-09-26 was -$351.00K.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-06-27 was -$309.00K.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2025 was -$2.27M.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2024 was -$3.55M.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2023 was -$736.00K, a 123.76% decline from fiscal 2022.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2022 was $3.10M, a 2228.57% increase from fiscal 2021.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|
| 2026-07-03 | -$1.18M 10-Q · filed 2026-08-04 | -$1.18M 10-Q · filed 2026-08-04 | ||
| 2025-12-31 | -$1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$1.96M derived: sum of 2 quarters · filed 2026-02-23 | -$2.27M derived: sum of 3 quarters · filed 2026-08-04 | -$2.27M 10-K · filed 2026-02-23 |
| 2025-09-26 | -$351.00K 10-Q · filed 2025-10-23 | -$660.00K derived: sum of 2 quarters · filed 2026-08-04 | -$660.00K 10-Q · filed 2025-10-23 | |
| 2025-06-27 | -$309.00K 10-Q · filed 2026-08-04 | -$309.00K 10-Q · filed 2026-08-04 | ||
| 2024-12-31 | -$3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$3.55M derived: sum of 2 quarters · filed 2026-02-23 | -$3.55M derived: sum of 3 quarters · filed 2026-02-23 | -$3.55M 10-K · filed 2026-02-23 |
| 2024-09-27 | $0.00 10-Q · filed 2025-10-23 | $0.00 derived: sum of 2 quarters · filed 2025-10-23 | $0.00 10-Q · filed 2025-10-23 | -$210.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-28 | $0.00 10-Q · filed 2025-07-24 | $0.00 10-Q · filed 2025-07-24 | -$210.00K derived: sum of 3 quarters · filed 2026-02-23 | -$471.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-29 | $0.00 10-Q · filed 2024-04-25 | -$210.00K derived: sum of 2 quarters · filed 2026-02-23 | -$471.00K derived: sum of 3 quarters · filed 2026-02-23 | -$471.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | -$210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$471.00K derived: sum of 2 quarters · filed 2026-02-23 | -$471.00K derived: sum of 3 quarters · filed 2026-02-23 | -$736.00K 10-K · filed 2026-02-23 |
| 2023-09-29 | -$261.00K 10-Q · filed 2024-10-24 | -$261.00K derived: sum of 2 quarters · filed 2024-10-24 | -$526.00K 10-Q · filed 2024-10-24 | $2.86M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $0.00 10-Q · filed 2024-07-25 | -$265.00K 10-Q · filed 2024-07-25 | $3.13M derived: sum of 3 quarters · filed 2025-02-20 | $2.78M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | -$265.00K 10-Q · filed 2024-04-25 | $3.13M derived: sum of 2 quarters · filed 2025-02-20 | $2.78M derived: sum of 3 quarters · filed 2025-02-20 | $2.78M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $3.04M derived: sum of 2 quarters · filed 2025-02-20 | $3.04M derived: sum of 3 quarters · filed 2025-02-20 | $3.10M 10-K · filed 2025-02-20 |
| 2022-09-30 | -$347.00K 10-Q · filed 2023-10-26 | -$347.00K derived: sum of 2 quarters · filed 2023-10-26 | -$293.00K 10-Q · filed 2023-10-26 | -$160.00K derived: sum of 4 quarters · filed 2023-10-26 |
| 2022-07-01 | $0.00 10-Q · filed 2023-07-27 | $54.00K 10-Q · filed 2023-07-27 | $187.00K derived: sum of 3 quarters · filed 2023-07-27 | $187.00K derived: sum of 4 quarters · filed 2023-07-27 |
| 2022-04-01 | $54.00K 10-Q · filed 2023-04-27 | $187.00K derived: sum of 2 quarters · filed 2023-04-27 | $187.00K derived: sum of 3 quarters · filed 2023-04-27 | $187.00K derived: sum of 4 quarters · filed 2023-04-27 |
| 2021-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $133.00K derived: sum of 2 quarters · filed 2023-02-21 | $133.00K derived: sum of 3 quarters · filed 2023-02-21 | $133.00K 10-K · filed 2023-02-21 |
| 2021-10-01 | $0.00 10-Q · filed 2022-10-27 | $0.00 derived: sum of 2 quarters · filed 2022-10-27 | $0.00 10-Q · filed 2022-10-27 | -$1.50M derived: sum of 4 quarters · filed 2022-10-27 |
| 2021-07-02 | $0.00 10-Q · filed 2022-07-28 | $0.00 10-Q · filed 2022-07-28 | -$1.50M derived: sum of 3 quarters · filed 2022-07-28 | -$1.50M derived: sum of 4 quarters · filed 2022-07-28 |
| 2021-04-02 | $0.00 10-Q · filed 2022-04-28 | -$1.50M derived: sum of 2 quarters · filed 2022-04-28 | -$1.50M derived: sum of 3 quarters · filed 2022-04-28 | -$1.50M derived: sum of 4 quarters · filed 2022-04-28 |
| 2020-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$1.50M derived: sum of 2 quarters · filed 2022-02-22 | -$1.50M derived: sum of 3 quarters · filed 2022-02-22 | -$2.00M 10-K · filed 2022-02-22 |
| 2020-10-02 | $0.00 10-Q · filed 2021-10-28 | $0.00 derived: sum of 2 quarters · filed 2021-10-28 | -$500.00K 10-Q · filed 2021-10-28 | |
| 2020-07-03 | $0.00 10-Q · filed 2021-07-29 | -$500.00K 10-Q · filed 2021-07-29 | ||
| 2020-04-03 | -$500.00K 10-Q · filed 2021-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |